/
Pharmaceutical preparations company · FY ends Dec · Revenue $7M · -602.14% margin · -$21M FCF
The business is unprofitable at the operating level (-712.66% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 78.3% YoY. Margins deteriorated 204.9pp alongside, both lines moving the wrong way.
Negative free cash flow of -$5M. The business is consuming cash, not generating it. Operating margin contracted 204.9pp YoY, cost discipline may be slipping.
Profitability & Returns
Revenue (TTM)
$7M
▼ -78.3% YoY
Net Income (TTM)
$164M
▲ +485.6% YoY
Op. Margin
-602.14%
▼ -204.9pp YoY
ROIC
-99.07%
▲ +6.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$21M
▲ +96.5% YoY
Op. Cash Flow (TTM)
-$21M
▲ +96.5% YoY
Net Debt
-$87M
Net Cash Position
Cash & Equiv.
$87M
5Y CAGR: -48.4%
Continue Research